| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |